Background Left ventricular diastolic dysfunction (LVDD) is an important precursor of heart
failure (HF), but little is known about its relationship with gut dysbiosis and microbial-related …

Heart failure (HF) is the end stage of most cardiovascular diseases and remains a significant
health problem globally. We aimed to assess whether patients with left ventricular ejection …

Growing evidence suggests an altered gut microbiome in patients with heart failure (HF).
However, the exact interrelationship between microbiota, HF, and its consequences on the …

Background Risk factors for heart failure with preserved ejection fraction (HFpEF) include
hypertension, age, sex, and obesity. Emerging evidence suggests that the gut microbiota …

Background Dysbiosis of the gut microbiome can impair metabolic regulation and promote
inflammation. Heart failure with preserved ejection fraction (HFpEF) is characterized by …

Growing evidence suggests an altered gut microbiome in patients with heart failure (HF).
However, the exact interrelationship between microbiota, HF, and its consequences on the …

Heart failure (HF) is a significant health concern; early detection and prevention are crucial.
Recent studies suggest that the gut microbiota and its metabolites may influence HF …

Aims: Scientists have recently discovered a link between the circulating microbiome and
homeostasis, as well as the pathogenesis of a number of metabolic diseases. It has been …

Type 2 diabetes (T2D) is associated with an increased risk of cardiovascular disease (CVD).
The gut microbiota may contribute to the onset and progression of T2D and CVD. The aim of …

A notable shift in understanding the human microbiome's influence on cardiovascular
disease (CVD) is underway, although the causal association remains elusive. A systematic …